- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02689076
Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Among older VA patients who have Medicare coverage, 43% use both VA and non-VA (Medicare-covered) services. VA and non-VA providers are often uninformed about encounters, treatments and test results provided in the other system. In particular, the absent or delayed notification of a non-VA hospital encounter is a missed opportunity for the VA to provide post-hospital transitional care services that have been shown to be effective in preventing adverse events and hospital readmission after hospital discharge. Objectives: The overall objective of this project is to examine the effectiveness, cost, and implementation acceptance of VA provider notification of non-VA hospitalization or emergency department (ED) visit using electronic health information exchange (HIE), with or without provision of evidence-based post-hospital transitional care services. Specific Aim 1 is to examine the impact of these approaches on preventing hospital admission or readmission as the primary outcome, and, as secondary outcomes, increasing provider follow-up, improving patient's condition self-knowledge, and preventing medication errors after discharge. been shown to be effective in preventing adverse events and hospital readmission after hospital discharge.
Specific Aim 2 is to examine the effect of these approaches on VA and non-VA costs. Specific Aim 3 is to examine the acceptance of these approaches among VA and non-VA stakeholders.
Methods: The study sample consists of Veterans followed in geriatrics or primary care clinics at the Bronx and Indianapolis VAs who are older than 65. The investigators will monitor patients for non-VA hospital admission or ED visit using technology provided by regional HIE organizations (i.e., the Bronx Regional Health Information Organization and the Indiana Health Information Exchange). Patients will be cluster-randomized 1:1 to notification-plus-coordination or notification-only groups by PACT team, stratified by facility. For both groups the PACT provider will receive real-time notification of a non-VA hospital admission or ED visit if it occurs. For the notification-plus-coordination group, a care transitions coordinator will deliver coordination activities during a home and/or VA facility visit and via follow-up phone calls over 1 month. Coordination activities will consist of: reconciliation of and counseling on the patient's VA and non-VA medications, education on signs of condition worsening, coordination of VA and non-VA follow-up appointments, and counseling on communicating with VA and non-VA providers, using structured protocols. All information-gathering by the transitions coordinator will include the HIE as an information source. The notification-only group will receive usual care after the notification. Multivariable regression models will be estimated to compare effects of notification-plus-coordination versus notification-only on primary and secondary outcomes and costs (Aims 1 and 2). The investigators will conduct interviews with intervention team members, patients, VA and non-VA staff, and other stakeholders to ascertain the barriers and facilitators to implementation of these approaches (Aim 3).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202-2884
- Richard L. Roudebush VA Medical Center, Indianapolis, IN
-
-
New York
-
Bronx, New York, United States, 10468-3904
- James J. Peters VA Medical Center, Bronx, NY
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- established patient in a Bronx VA or Indianapolis VA geriatrics or primary care clinic
- 65 years or older
- be consented in the local health information exchange
have utilized any non-VA services in the previous two years, including:
- nursing
- lab
- physician
- pharmacy
- and/or hospital services
Exclusion Criteria:
- Refusal to sign informed consent or consent to access local health information exchange
- Enrolled in hospice at baseline
- Enrolled in Geriatric Resources and Care for Elders (GRACE) program (Indianapolis) at baseline
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: HIE Notification plus Care Coordination
VA provider notification of non-VA hospitalization via electronic health information exchange (HIE) plus post-hospital geriatric care transitions intervention
|
VA provider notification of non-VA hospitalization or ED visit via electronic health information exchange
Post-hospital geriatrics care transitions coordinator provides home visit and telephone support for 30 days after hospital discharge
|
Active Comparator: HIE Notification alone
VA provider notification of non-VA hospitalization via electronic health information exchange (HIE) followed by usual post-hospital care
|
VA provider notification of non-VA hospitalization or ED visit via electronic health information exchange
|
No Intervention: Usual Care (No HIE Notification and No Care Coordination)
Absence of VA provider notification of non-VA hospitalization via HIE plus Absence of post-hospital geriatric care transitions intervention [Usual Care]
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Hospital Readmission
Time Frame: 90 days
|
Percentage of patients with VA and non-VA hospital admission or readmission 90 days after non-VA hospital or ED discharge (or, if the patient is not discharged home, 90 days after discharge home from a rehabilitation facility)
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Scheduled Follow-up
Time Frame: 30 days
|
VA follow-up visit with a VA provider (physician or nurse practitioner) within 30 days of non-VA hospital discharge or ED visit.
|
30 days
|
Number of High-risk Medication Discrepancies
Time Frame: 30 days
|
The number of discrepancies in medications classified as high risk for hospitalized older adults, including opioid analgesics, insulin, non-steroidal anti-inflammatory drugs, digoxin, antipsychotics, sedatives/hypnotics, and anticoagulants based on medical record review and patient or caregiver interview 30 days after non-VA hospital discharge.
|
30 days
|
Care Transitions Measure Score
Time Frame: 30 days
|
A measure of condition self-knowledge and transitional care quality from the patient's perspective is ascertained by patient or caregiver interview 30 days after non-VA hospital discharge.
The investigators will use an adapted 3-item version which includes items such as: "After I left the hospital, I had all the information I needed to be able to take care of myself" with the response options strongly agree, agree, disagree, strongly disagree, and don't know.
The investigators chose to use the 3-item rather than a 15-item version as the shorter instrument demonstrates excellent correlation with the longer version but with lower respondent burden.
Unabbreviated scale title is "3-Item Care Transitions Measure" and minimum value is 1 and maximum value is 12. Higher scores mean a better transition/outcome.
|
30 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kenneth S Boockvar, MD MS, James J. Peters Veterans Affairs Medical Center
Publications and helpful links
General Publications
- Dixon BE, Boockvar KS. Event Notification in Support of Population Health: The Promise and Challenges from a Randomized Controlled Trial. Stud Health Technol Inform. 2017;245:1357.
- Dixon BE, Schwartzkopf AL, Guerrero VM, May J, Koufacos NS, Bean AM, Penrod JD, Schubert CC, Boockvar KS. Regional data exchange to improve care for veterans after non-VA hospitalization: a randomized controlled trial. BMC Med Inform Decis Mak. 2019 Jul 4;19(1):125. doi: 10.1186/s12911-019-0849-1.
- Franzosa E, Traylor MH, Aquino VG, Judon K, Schwartzkopf A, Dixon BE, Boockvar K. Care Team Members' Perceptions of an Informatics Intervention to Improve Geriatric Care Across Multiple sites. [Abstract]. Innovation in aging. 2020 Dec 16; 4(Supplement_1):519.
- Franzosa E, Traylor M, Judon KM, Guerrero Aquino V, Schwartzkopf AL, Boockvar KS, Dixon BE. Perceptions of event notification following discharge to improve geriatric care: qualitative interviews of care team members from a 2-site cluster randomized trial. J Am Med Inform Assoc. 2021 Jul 30;28(8):1728-1735. doi: 10.1093/jamia/ocab074.
- Kartje R, Dixon BE, Schwartzkopf AL, Guerrero V, Judon KM, Yi JC, Boockvar K. Characteristics of Veterans With Non-VA Encounters Enrolled in a Trial of Standards-Based, Interoperable Event Notification and Care Coordination. J Am Board Fam Med. 2021 Mar-Apr;34(2):301-308. doi: 10.3122/jabfm.2021.02.200251.
- Koufacos NS, May J, Judon KM, Franzosa E, Dixon BE, Schubert CC, Schwartzkopf AL, Guerrero VM, Traylor M, Boockvar KS. Improving Patient Activation among Older Veterans: Results from a Social Worker-Led Care Transitions Intervention. J Gerontol Soc Work. 2022 Jan;65(1):63-77. doi: 10.1080/01634372.2021.1932003. Epub 2021 May 30.
- Dixon BE, Judon KM, Schwartzkopf AL, Guerrero VM, Koufacos NS, May J, Schubert CC, Boockvar KS. Impact of event notification services on timely follow-up and rehospitalization among primary care patients at two Veterans Affairs Medical Centers. J Am Med Inform Assoc. 2021 Nov 25;28(12):2593-2600. doi: 10.1093/jamia/ocab189.
- Boockvar KS, Koufacos NS, May J, Schwartzkopf AL, Guerrero VM, Judon KM, Schubert CC, Franzosa E, Dixon BE. Effect of Health Information Exchange Plus a Care Transitions Intervention on Post-Hospital Outcomes Among VA Primary Care Patients: a Randomized Clinical Trial. J Gen Intern Med. 2022 Dec;37(16):4054-4061. doi: 10.1007/s11606-022-07397-5. Epub 2022 Feb 23.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIR 14-049
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adverse Drug Event
-
University of RochesterAgency for Healthcare Research and Quality (AHRQ)CompletedAdverse Drug Event, Potential Adverse Drug Event, and Quality MeasuresUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Vancouver Coastal Health; Ministry...Not yet recruitingAdverse Drug Event | Adverse Drug Reaction
-
University of PittsburghRANDCompletedAdverse Drug EventsUnited States
-
US Department of Veterans AffairsCompletedAdverse Drug EventsUnited States
-
Westview Physician CollaborativeCompletedAdverse Drug EventsCanada
-
Ottawa Hospital Research InstituteMcGill University; Canadian Institutes of Health Research (CIHR)CompletedAdverse Drug EventsCanada
-
Intermountain Health Care, Inc.Completed
-
Cedars-Sinai Medical CenterNational Institutes of Health (NIH); National Institute on Aging (NIA)Completed
-
University of Massachusetts, WorcesterAgency for Healthcare Research and Quality (AHRQ); Baycrest Centre for Geriatric...WithdrawnAdverse Drug Events
-
Indiana UniversityBrigham and Women's HospitalCompleted
Clinical Trials on HIE Notification
-
VA Office of Research and DevelopmentIcahn School of Medicine at Mount Sinai; Weill Medical College of Cornell University and other collaboratorsCompleted
-
Brigham and Women's HospitalAgency for Healthcare Research and Quality (AHRQ)RecruitingGastrointestinal Diseases | Heart Failure | Infections | Urologic Diseases | Shock | Hematologic Diseases | Critical Illness | Rheumatic Diseases | Asthma | Renal Failure | Neurologic Disorder | COPD Exacerbation | Cardiac Event | Oncology Problem | Arrythmia | Renal DiseaseUnited States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Department...CompletedUpper Gastrointestinal BleedingUnited States
-
Seoul St. Mary's HospitalSaint Vincent's Hospital, Korea; Uijeongbu St. Mary HospitalCompletedColonoscopy | Human CharacteristicsKorea, Republic of
-
Duke UniversityCompletedAdvance Care PlanningUnited States
-
Brigham and Women's HospitalCompletedTest Result ManagementUnited States
-
Columbia UniversityNational Institute of Nursing Research (NINR); Brigham and Women's HospitalCompleted
-
Columbia UniversityCompleted
-
University of North Carolina, Chapel HillCompleted
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute; Brigham and Women's Hospital; M... and other collaboratorsActive, not recruitingColorectal Cancer ScreeningUnited States